These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2727039)

  • 1. [The in vitro release rate of isosorbide dinitrate in a transdermal therapeutic membrane system].
    Janicki S; Gabiga H
    Pharmazie; 1989 Jan; 44(1):68-9. PubMed ID: 2727039
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on transdermal delivery system of isosorbide dinitrate].
    Ji AM; Jiang XT; Wang XF; Zou HQ
    Yao Xue Xue Bao; 1992; 27(11):858-63. PubMed ID: 1300032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vivo penetration of isosorbide dinitrate from a transdermal therapeutic system in rat skin].
    Janicki S; Gabiga H; Szczepańska M
    Pharmazie; 1993 Nov; 48(11):865. PubMed ID: 8295920
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antianginal effect of transdermal isosorbide dinitrate (multicenter study)].
    Kékes E
    Orv Hetil; 1994 Oct; 135(44):2421-3. PubMed ID: 7970662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sorption of isosorbide dinitrate on infusion sets].
    Springer V; Struhár M; Springerová Z
    Pharmazie; 1989 Jul; 44(7):500-1. PubMed ID: 2813492
    [No Abstract]   [Full Text] [Related]  

  • 7. Transdermal drug delivery: a review of pharmaceutics, pharmacokinetics, and pharmacodynamics.
    Moore L; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1988; 4(4):285-349. PubMed ID: 3133121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a membrane-controlled transdermal therapeutic system containing isosorbide dinitrate.
    Ocak F; Ağabeyoğlu I
    Int J Pharm; 1999 Apr; 180(2):177-83. PubMed ID: 10370188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isosorbide dinitrate spray as therapeutic strategy for treatment of chronic venous ulcers.
    Sánchez-Vázquez R; Briseño-Rodríguez G; Cardona-Muñoz EG; Gálvez-Gastélum FJ; Totsuka-Sutto SE; Garcia-Benavides L
    Angiology; 2008; 59(1):64-71. PubMed ID: 18319224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane permeation-controlled transdermal delivery system design. Influence of controlling membrane and adhesive on skin permeation of isosorbide dinitrate.
    Seki T; Kawaguchi T; Sugibayashi K; Juni K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):740-3. PubMed ID: 2347017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transdermal therapy of stable angina pectoris. Comparison of 2 different transdermal systems].
    Kramar M; Giersch KH; Schneider HT
    Fortschr Med; 1987 Jun; 105(17):340-2. PubMed ID: 3111961
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic range of transdermal nitro-patches].
    Lazebnik LB
    Klin Med (Mosk); 1995; 73(5):47-50. PubMed ID: 8815277
    [No Abstract]   [Full Text] [Related]  

  • 13. Absorption of isosorbide dinitrate by PVC infusion bags and administration sets.
    Lee MG; Fenton-May V
    J Clin Hosp Pharm; 1981 Sep; 6(3):209-11. PubMed ID: 7298865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effects of isosorbide dinitrate in the transdermal spray (TD Spray Iso Mack) form].
    Vítovec J; Stejfa M; Blaha M; Nĕmcová H; Roubalík P; Spác J
    Vnitr Lek; 1989 Aug; 35(8):758-64. PubMed ID: 2800383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal slow-release long-acting isosorbide dinitrate for 'nutcracker' oesophagus: an open study.
    Tursi A; Brandimarte G; Gasbarrini G
    Eur J Gastroenterol Hepatol; 2000 Sep; 12(9):1061-2. PubMed ID: 11007147
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic and anti-angina effects of transdermal nitroglycerin after acute and chronic administration. Additive effect of sublingual isosorbide dinitrate].
    Scardi S; Pandullo C; Pivotti F; Ceschia G; Pollavini G
    G Ital Cardiol; 1986 Nov; 16(11):895-903. PubMed ID: 3104123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled-release isosorbide dinitrate pellets. Part I: Design and evaluation of controlled-release capsule dosage form.
    Lalla JK; Bhat SU
    J Pharm Sci; 1993 Dec; 82(12):1288-91. PubMed ID: 8308715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the effects of depot peroral and transdermal administration of nitrate preparations].
    Camek R; Karetová D; Bultas J; Krupicka P; Boudĭk F; Fabian E
    Vnitr Lek; 1988 Feb; 34(2):122-9. PubMed ID: 3129873
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetics of 14C-isosorbide dinitrate after administration in various sustained-release formulations].
    Chasseaud LF; Taylor T; Major RM; Taylor IW; Luckow V; Darragh A; Lambe RF
    Arzneimittelforschung; 1983; 33(9):1298-301. PubMed ID: 6685511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron beam irradiation: a novel technology for the development of transdermal system of isosorbide dinitrate.
    Kotiyan PN; Vavia PR; Bhardwaj YK; Sabarwal S; Majali AB
    Int J Pharm; 2004 Feb; 270(1-2):47-54. PubMed ID: 14726121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.